{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:86281"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:86281","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Length polymorphisms in the hypervariable region-1 of hepatitis C virus E2: a novel regulator of viral entry and neutralisation","abstract":"Currently 50 million people globally are living with Hepatitis C Virus (HCV). Whilst direct-acting antivirals offer a cure, there is no vaccine for HCV. One major barrier to the development of an effective HCV vaccine is the lack of mechanistic understanding of E1E2, the HCV viral entry proteins. Of particular importance for vaccine design is the Hypervariable Region-1 (HVR-1) of the E2 glycoprotein. HVR-1 is an intrinsically disordered tail which mediates entry and immune evasion through an unknown mechanism. Through state-of-the-art machine learning-enabled protein structure prediction, bioinformatic analysis, and in vitro experiments, we investigated how length polymorphisms in the HVR- 1 contribute to phenotype. We analysed 30,289 sequences covering >25 % of the E2 protein. To examine distribution of length polymorphisms across HCV genotypes, 9,103 unique HVR-1 sequences were extracted from this dataset and assessed. To evaluate HVR-1 conformation, we modelled 105 E2 proteins, and 96 E1E2 protein complexes using different protein structure prediction software platforms. To investigate how length polymorphisms in the HVR-1 affect virus phenotype, we cloned HVR- 1s of varying length into the prototypical J6 HCV to produce HCV pseudoparticles (HCVpp). We evaluated the infectivity, receptor dependency, and antibody sensitivity of this panel of HCVpp. Moreover, we produced sE2 proteins with the same length polymorphisms in the HVR-1 and interrogated their ability to bind SR-B1. This study found that the HVR-1 is predicted to be positioned in distinct conformations, length polymorphisms are common across all HCV genotypes, and length polymorphisms can modulate infectivity, receptor dependency, and neutralisation. Additionally, the sE2 experiments demonstrated that SR-B1 dependency and SR-B1 binding are uncoupled. These data allowed us to pull apart some of the molecular mechanism of the HVR-1. Altogether, this work suggests that the ability of the HVR-1 to adopt certain conformational states may correlate with phenotype. Moreover, length polymorphisms represent one way for HCV to fine tune the function of the HVR-1.","abstract_html":"Currently 50 million people globally are living with Hepatitis C Virus (HCV). Whilst direct-acting antivirals offer a cure, there is no vaccine for HCV. One major barrier to the development of an effective HCV vaccine is the lack of mechanistic understanding of E1E2, the HCV viral entry proteins. Of particular importance for vaccine design is the Hypervariable Region-1 (HVR-1) of the E2 glycoprotein. HVR-1 is an intrinsically disordered tail which mediates entry and immune evasion through an unknown mechanism. Through state-of-the-art machine learning-enabled protein structure prediction, bioinformatic analysis, and in vitro experiments, we investigated how length polymorphisms in the HVR- 1 contribute to phenotype. We analysed 30,289 sequences covering &gt;25 % of the E2 protein. To examine distribution of length polymorphisms across HCV genotypes, 9,103 unique HVR-1 sequences were extracted from this dataset and assessed. To evaluate HVR-1 conformation, we modelled 105 E2 proteins, and 96 E1E2 protein complexes using different protein structure prediction software platforms. To investigate how length polymorphisms in the HVR-1 affect virus phenotype, we cloned HVR- 1s of varying length into the prototypical J6 HCV to produce HCV pseudoparticles (HCVpp). We evaluated the infectivity, receptor dependency, and antibody sensitivity of this panel of HCVpp. Moreover, we produced sE2 proteins with the same length polymorphisms in the HVR-1 and interrogated their ability to bind SR-B1. This study found that the HVR-1 is predicted to be positioned in distinct conformations, length polymorphisms are common across all HCV genotypes, and length polymorphisms can modulate infectivity, receptor dependency, and neutralisation. Additionally, the sE2 experiments demonstrated that SR-B1 dependency and SR-B1 binding are uncoupled. These data allowed us to pull apart some of the molecular mechanism of the HVR-1. Altogether, this work suggests that the ability of the HVR-1 to adopt certain conformational states may correlate with phenotype. Moreover, length polymorphisms represent one way for HCV to fine tune the function of the HVR-1.","abstract_has_math":false,"creators":["Devlin, Stephen"],"institution":"University of Glasgow","degree_name":null,"degree_level":"PhD","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-19T08:37:50Z","subjects":["QR355 Virology"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.5525/gla.thesis.86281","outbound_label":"DOI","outbound_source":"dc:identifier.doi","record_url":"https://doi.org/10.5525/gla.thesis.86281","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier.doi","download_url":"https://theses.gla.ac.uk/86281/1/2026DevlinPhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A86281","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Devlin, Stephen"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/86281/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR355 Virology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.5525/gla.thesis.86281"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/86281/1/2026DevlinPhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Currently 50 million people globally are living with Hepatitis C Virus (HCV). Whilst direct-acting antivirals offer a cure, there is no vaccine for HCV. One major barrier to the development of an effective HCV vaccine is the lack of mechanistic understanding of E1E2, the HCV viral entry proteins. Of particular importance for vaccine design is the Hypervariable Region-1 (HVR-1) of the E2 glycoprotein. HVR-1 is an intrinsically disordered tail which mediates entry and immune evasion through an unknown mechanism. Through state-of-the-art machine learning-enabled protein structure prediction, bioinformatic analysis, and in vitro experiments, we investigated how length polymorphisms in the HVR- 1 contribute to phenotype. We analysed 30,289 sequences covering >25 % of the E2 protein. To examine distribution of length polymorphisms across HCV genotypes, 9,103 unique HVR-1 sequences were extracted from this dataset and assessed. To evaluate HVR-1 conformation, we modelled 105 E2 proteins, and 96 E1E2 protein complexes using different protein structure prediction software platforms. To investigate how length polymorphisms in the HVR-1 affect virus phenotype, we cloned HVR- 1s of varying length into the prototypical J6 HCV to produce HCV pseudoparticles (HCVpp). We evaluated the infectivity, receptor dependency, and antibody sensitivity of this panel of HCVpp. Moreover, we produced sE2 proteins with the same length polymorphisms in the HVR-1 and interrogated their ability to bind SR-B1. This study found that the HVR-1 is predicted to be positioned in distinct conformations, length polymorphisms are common across all HCV genotypes, and length polymorphisms can modulate infectivity, receptor dependency, and neutralisation. Additionally, the sE2 experiments demonstrated that SR-B1 dependency and SR-B1 binding are uncoupled. These data allowed us to pull apart some of the molecular mechanism of the HVR-1. Altogether, this work suggests that the ability of the HVR-1 to adopt certain conformational states may correlate with phenotype. Moreover, length polymorphisms represent one way for HCV to fine tune the function of the HVR-1."]},{"key":"dc:format","label":"Dc Format","values":["pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Length polymorphisms in the hypervariable region-1 of hepatitis C virus E2: a novel regulator of viral entry and neutralisation"]}]}],"canonical_facts":{"dc:creator":["Devlin, Stephen"],"dc:date":["2026"],"dc:date.issued":["2026"],"dc:description.abstract":["Currently 50 million people globally are living with Hepatitis C Virus (HCV). Whilst direct-acting antivirals offer a cure, there is no vaccine for HCV. One major barrier to the development of an effective HCV vaccine is the lack of mechanistic understanding of E1E2, the HCV viral entry proteins. Of particular importance for vaccine design is the Hypervariable Region-1 (HVR-1) of the E2 glycoprotein. HVR-1 is an intrinsically disordered tail which mediates entry and immune evasion through an unknown mechanism. Through state-of-the-art machine learning-enabled protein structure prediction, bioinformatic analysis, and in vitro experiments, we investigated how length polymorphisms in the HVR- 1 contribute to phenotype. We analysed 30,289 sequences covering >25 % of the E2 protein. To examine distribution of length polymorphisms across HCV genotypes, 9,103 unique HVR-1 sequences were extracted from this dataset and assessed. To evaluate HVR-1 conformation, we modelled 105 E2 proteins, and 96 E1E2 protein complexes using different protein structure prediction software platforms. To investigate how length polymorphisms in the HVR-1 affect virus phenotype, we cloned HVR- 1s of varying length into the prototypical J6 HCV to produce HCV pseudoparticles (HCVpp). We evaluated the infectivity, receptor dependency, and antibody sensitivity of this panel of HCVpp. Moreover, we produced sE2 proteins with the same length polymorphisms in the HVR-1 and interrogated their ability to bind SR-B1. This study found that the HVR-1 is predicted to be positioned in distinct conformations, length polymorphisms are common across all HCV genotypes, and length polymorphisms can modulate infectivity, receptor dependency, and neutralisation. Additionally, the sE2 experiments demonstrated that SR-B1 dependency and SR-B1 binding are uncoupled. These data allowed us to pull apart some of the molecular mechanism of the HVR-1. Altogether, this work suggests that the ability of the HVR-1 to adopt certain conformational states may correlate with phenotype. Moreover, length polymorphisms represent one way for HCV to fine tune the function of the HVR-1."],"dc:format":["pdf"],"dc:identifier.doi":["10.5525/gla.thesis.86281"],"dc:identifier.uri":["https://theses.gla.ac.uk/86281/1/2026DevlinPhD.pdf"],"dc:language":["en"],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/86281/"],"dc:subject":["QR355 Virology"],"dcterms:accessrights":["public"],"dc:title":["Length polymorphisms in the hypervariable region-1 of hepatitis C virus E2: a novel regulator of viral entry and neutralisation"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["PhD"]},"updated_at":"2026-11-19T08:37:50Z"}